Zai Lab (ZLAB) Other financing activities (2019 - 2026)
Zai Lab (ZLAB) posted quarterly Other financing activities of $833000.0 for Q1 2026, down 72.32% year-on-year from $3.0 million in Q1 2025, and up 234.54% on a QoQ basis from $249000.0 in Q4 2025.
Zai Lab (ZLAB) Other financing activities (2019 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Other financing activities for 8 consecutive years, with $833000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other financing activities fell 72.32% year-over-year to $833000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 85.2% YoY) and the FY2025 annual result came in at $13.7 million, up 327.34% from the prior year.
- Other financing activities climbed to $833000.0 in Q1 2026 per ZLAB's latest filing, from $249000.0 in the prior quarter.
- Over the last five years, Other financing activities for ZLAB reached as high as $8.4 million in Q2 2025 and fell as low as $44000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $927000.0 in 2022 frame the typical range for Other financing activities.
- The largest YoY upside for Other financing activities was 22900.0% in 2022 against a maximum downside of 99.47% in 2022.
- Year by year, Other financing activities stood at $230000.0 in 2022, then jumped by 104.35% to $470000.0 in 2023, then soared by 299.79% to $1.9 million in 2024, then plunged by 86.75% to $249000.0 in 2025, then surged by 234.54% to $833000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $833000.0, $249000.0, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 833,000.00 |
| Mar 31, 2026 | 833,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Sep 30, 2023 | 137,000.00 |
| Sep 30, 2023 | 137,000.00 |